Combination of evofosfamide and chemotherapy suppress tumor growth than using these drugs alone. The purpose of this study is to detect physiologic changes in tumor-bearing mouse model in response to combination of evofosfamide and gemcitabine (GEM) using multi-modal imaging methods including DCE-MRI, blood volume imaging, and EPRI. Significantly increased perfusion, maintained blood volume, and maintained hypoxic fraction < 10 mmHg were observed after treatment with combination of evofosfamide and GEM. The results validate the utility of these imaging methods to non-invasively monitor changes in the tumor microenvironment after treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords